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With this study, we explored the potential role of fungal endophytes in the 
antimicrobial activity of the medicinal plant goldenseal, Hydrastis canadensis L. 
(Ranunculaceae). A total of 23 fungal cultures were obtained from surface-sterilized 
samples of H. canadensis roots, leaves and seeds. Eleven secondary metabolites were 
isolated from these fungal endophytes, five of which had reported antimicrobial activity.  
Hydrastis canadensis plant material from the same harvest was analyzed for the presence 
of fungal metabolites using liquid chromatography coupled to high resolving power mass 
spectrometry. One fungal metabolite, the antimicrobial compound alternariol 
monomethyl ether, was detected both as a metabolite of the fungal endophyte Alternaria 
sp. isolated from H. canadensis seeds and as a component of an extract from the H. 
canadensis seed material.  The concentration of this compound (991 mg/kg in dry seed 
material) was in a higher abundance than has previously been reported for metabolites of 
ecologically important fungal endophytes. The seed extracts themselves, however, 
possessed slight antimicrobial activity.  
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CHAPTER I 
INTRODUCTION 
 This study focuses on endophytic fungi, which live asymptomatically within plant 
tissues, and the secondary metabolites that they biosynthesize. There has recently been a 
great deal of interest in endophytic fungi as a source for natural product drug discovery 
(Strobel, 2003; Suryanarayanan et al., 2009). It has been shown that endophytic fungi can 
have positive effects on their host plants, including improving drought tolerance, and 
producing protective compounds (Bush et al., 1997). Bioactive components from 
endophytic fungi have been shown to possess a number of different activities against 
human pathogens, and to possess novel cytotoxicity mechanisms (Strobel, 2003). It has 
also been shown that some fungal endophytes produce the same bioactive components 
found in botanicals they inhabit, which suggests that the influence of an endophyte may 
go beyond that of basic protection (El-Elimat et al., 2014; Kusari et al., 2013; Nisa et al., 
2015; Stierle et al., 1993).  
Because endophytic fungi are present in plant tissues, it has been suggested that 
compounds originating from endophytes may play a role in the biological activity of 
botanical extracts. There have been a few cases where this has been shown to be true for 
endophytic bacteria, which alter the in vitro anti-inflammatory activity of Echinacea 
extracts (Pugh et al., 2013; Todd et al., 2015).  It is well known that fungal secondary 
metabolites can demonstrate potent biological effects, which supports the hypothesis that 
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fungal symbionts could also contribute to or alter the biological activity of botanical 
extracts.  The goal of this study was to explore the potential role of fungal endophytes in 
the antimicrobial activity of the botanical medicine goldenseal, Hydrastis canadensis L. 
(Ranunculaceae). 
It has previously been shown that H. canadensis has antimicrobial activity against 
a number of bacterial pathogens, and this activity has primarily been attributed to the 
alkaloid berberine (Hwang et al., 2003; Scazzocchio et al., 2001). However, several 
studies have demonstrated that the antimicrobial activity of goldenseal crude extracts is 
more pronounced than that of isolated berberine, suggesting that other compounds must 
also play a role (Ettefagh et al., 2011; Junio et al., 2011).  With this study, we sought to 
isolate and identify fungal endophytes from H. canadensis plant material and determine 
whether their metabolites contribute to the antimicrobial activity of goldenseal botanical 
extracts.  
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CHAPTER II  
RESULTS AND DISCUSSION 
Endophyte Identities and Activities 
 
 Endophytic fungi, a total of 23 isolates, were cultured and identified from 
Hydrastis canadensis.  The fungi were identified based on fragments of complete 
ITSrDNA; approximately 600-650 bp.  Five isolates were identified as Alternaria sp., six 
as Colletotrichum fioriniae, three as Diaporthe eres, four as Diaporthe sp., two as 
Sordariomycete sp., one as Magnaporthales sp., one as Phoma sp., and one as 
Pyrenocheta cava (Table 1).  A number of the fungal extracts possessed marked 
antimicrobial activity against Staphylococcus aureus, with the most pronounced activity 
observed for Alternaria sp.  (Table 3).   
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Table 1. Identities of Endophytic Fungi. G numbers were assigned for in house 
identification, and OTU identification was performed via ITS rDNA sequencing 
G# 
OTU 
identification 
Species identification of most homologous sequence from 
GenBank based on BLAST search* 
Origin from  
Plant source 
Reference 
G09 Diaporthe eres Diaporthe eres (= Diaporthe cotonesteri; NR_119726) 
Leaf (Udayanga et al., 
2014) 
G10 Diaporthe sp. Diaporthe terebinthifolii (NR_111862) 
Leaf (Gomes et al., 
2013) 
G11 
Sordariomycete sp. 
(Xylariales) 
Sordariomycete sp. NC1024 (JQ761762) 
Leaf (U’Ren et al., 
2012) 
G12 
Colletotrichum 
fioriniae 
Colletotrichum fioriniae (NR_117474, EF464594) 
(JN709486) 
Stem (Damm et al., 
2012; Shivas and 
Yu, 2009)  
G13 Alternaria sp. 
Alternaria daucifolii (KC584193); Alternaria eichhorniae 
(NR_111832) 
Stem (Woudenberg et 
al., 2013) 
G14 Diaporthe eres Diaporthe eres (= Diaporthe cotonesteri; NR_119726) 
Stem (Udayanga et al., 
2014) 
G15 Diaporthe eres Diaporthe eres (= Diaporthe cotonesteri; NR_119726) 
Stem (Udayanga et al., 
2014) 
G16 Diaporthe sp. Diaporthe eucalyptorum (NR_120157) 
Root (Crous et al., 
2012) 
G17 Diaporthe sp. Diaporthe eucalyptorum (NR_120157) 
Root (Crous et al., 
2012) 
G22 Phoma sp. Phoma bellidis (GU237904) 
Leaf (Aveskamp et al., 
2010) 
G23 
Magnaporthales 
sp. 
Mycoleptodiscus terrestris (JN711860) 
Root 
(Koo et al., 2012) 
G28 Alternaria sp. 
Alternaria daucifolii (KC584193); Alternaria eichhorniae 
(NR_111832) 
Seed (Woudenberg et 
al., 2013) 
G29 Diaporthe sp. Diaporthe terebinthifolii (NR_111862) 
Seed (Gomes et al., 
2013) 
G30 
Colletotrichum 
fioriniae 
Colletotrichum fioriniae (NR_117474, EF464594) 
(JN709486) 
Seed (Damm et al., 
2012; Shivas and 
Yu, 2009) 
G31 Alternaria sp. 
Alternaria daucifolii (KC584193); Alternaria eichhorniae 
(NR_111832) 
Seed (Woudenberg et 
al., 2013) 
G33 Alternaria sp. 
Alternaria daucifolii (KC584193); Alternaria eichhorniae 
(NR_111832) 
Seed (Woudenberg et 
al., 2013) 
G34 
Colletotrichum 
fioriniae 
Colletotrichum fioriniae (NR_117474, EF464594) 
(JN709486) 
Seed (Damm et al., 
2012; Shivas and 
Yu, 2009) 
G35 
Colletotrichum 
fioriniae 
Colletotrichum fioriniae (NR_117474, EF464594) 
(JN709486) 
Seed (Damm et al., 
2012; Shivas and 
Yu, 2009) 
G36 Alternaria sp. 
Alternaria daucifolii (KC584193); Alternaria eichhorniae 
(NR_111832) 
Seed (Woudenberg et 
al., 2013) 
G38 
Colletotrichum 
fioriniae 
Colletotrichum fioriniae (NR_117474, EF464594) 
(JN709486) 
Seed (Damm et al., 
2012; Shivas and 
Yu, 2009) 
G39 
Colletotrichum 
fioriniae 
Colletotrichum fioriniae (NR_117474, EF464594) 
(JN709486) 
Seed (Damm et al., 
2012; Shivas and 
Yu, 2009) 
G41 Pyrenochaeta sp. Pyrenochaeta sp. (EU885415) 
Leaf (Ferrer et al., 
2009) 
G42 
Sordariomycete sp. 
(Xylariales) 
Sordariomycete sp. NC1024 (JQ761762) 
Leaf (U’Ren et al., 
2012) 
 
*Fungal endophyte OTUs were tentatively assigned to either genus or species by 
matching the most homologous sequences in GenBank by BLAST search. Mainly 
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authentic sequences were used for assigning OTUs preferentially from type or other 
authentic, and annotated cultures generated by taxonomic specialist published in high 
impact factor Mycology journals. When multiple species were found to have high 
sequence similarity, or when <97% sequence homology was found with a published 
authentic sequence for which a culture was deposited in a public culture collection, we 
choose to take a more conservative approach and use only the genus, family, order, class 
name for OTU assignment (see Raja et al., 2015)  
Fungal Metabolites 
 
 A total of eleven secondary metabolites, all of which are known compounds, were 
identified from the fungal isolates (Figure 1, Table 4).   The compounds alternariol (1), 
alternariol monomethyl ether (2), 5’epi-equisetin (3) equisetin (4), 10-11 
dehydrocurvularin (5), macrosphelide A (6), and cordipyridone A (7) , were isolated with 
chromatographic approaches and their spectroscopic data (accurate mass, 1H NMR, and 
13C NMR) matched literature reports (Table 4).   The remaining compounds, Sch 52901 
(8), Sch 52900 (9), Verticillin A (10), Aurofusarin (11) were identified by comparison of 
LC-MS data with a library of previously isolated fungal metabolites (El-Elimat et al., 
2013a; Figueroa et al., 2014).   
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Figure 1. Metabolites from Endophytic Fungi of Hydrastis canadensis. 
 
Isolated metabolites, Alternariol (1), Alternariol monomethyl ether (2), 5’-epiquisetin (3), 
Equisetin (4), 10-11 Didehydrocurvularin (5), Macrosphelide A (6), Cordypyridone A 
(7), were found to be >95% Pure by UV/Vis. Metabolites Sch 52901 (8), Sch 52900 (9), 
Verticillin A (10), Aurofusarin (11) were verified via UPLC-MS/MS dereplication 
against an in-house database.  
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Presence of Fungal Metabolites in Plant Material 
 
Of the eleven metabolites identified from the fungal endophytes, one compound, 
alternariol monomethyl ether (2), was detected in a botanical extract with the methods 
employed here.  Retention time, accurate mass ([M+H]+, 273.0754, calcd for C15H13O5
+, 
273.0763), and MS-MS fragmentation pattern for the putative alternariol monomethyl 
ether ion in the extract matched that of isolated alternariol monomethyl ether (Figure 2).  
The alternariol monomethyl ether was detected in two adjacent normal phase 
chromatography fractions of a seed extract from H. canadensis.  This compound was 
absent from other fractions of the same extract and from blank injections conducted 
before each extract analysis.  Additionally, extracts from the other plant parts of H. 
canadensis did not contain detectable levels of alternariol monomethyl ether.  Finally, 
alternariol monomethyl ether was also absent from another collection of H. canadensis 
seeds, which were harvested from the same plot but at a later date.   
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Figure 2. Selected Ion Chromatogram for m/z 273.0755 in a Concentrated Fraction 
From an Extract of H. canadensis Seeds (Analyzed at 1mg/mL) 
 
(A) and isolated alternariol monomethyl ether from Alternaria sp. at a concentration of 
1mg/mL (B). MS-MS fragmentation patterns for the precursor ion at m/z 273.0754 are in 
excellent agreement between the compound detected in the plant material (C) and 
isolated alternariol monomethyl ether (D). 
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Consistent with the presence of alternariol monomethyl ether in the botanical seed 
extract, this compound was also isolated from two H. canadensis seed endophytes 
(Alternaria sp., G13 and G31, Table 1).  Interestingly, Alternaria spp. are known to exist 
both as endophytes and plant pathogens (Woudenberg et al., 2013).  Thus, it is possible 
that this fungus inhabits H. canadensis seeds as a means of transmission to H. canadensis 
seedlings.  At the same time, the fungus may confer a protective effect on the seeds by 
producing antimicrobial compounds.  Consistent with these observations, Alternaria spp. 
were identified in collections of goldenseal from the same plot over a multiyear time 
course. A collection done on 6/28/2012 provided an additional case of Alternaria sp 
(G275) being identified from the seed material. ITS sequencing placed this strain of 
Alternaria sp (G275) as being highly similar to the Alternaria sp (G31) identified in the 
initial collection. Furthermore, a third collection of goldenseal from this plot done on 
6/11/2015 yielded an endophyte from the stem segments that was a producer of 
alternariol monomethyl ether. This endophyte was noted as being morphologically 
similar to an Alternaria sp. and sequencing is currently being done to confirm the identity 
of the species. Additional efforts are underway for the characterization and identification 
of fungal endophytes from the collections done on 6/28/2012 and 6/11/2016.  
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 Antimicrobial Activity of Fungal Metabolites and Botanical Extracts 
 
To explore the potential relevance of alternariol monomethyl ether to the 
biological activity of H. canadensis, antimicrobial activity against S. aureus was 
measured for all of the botanical extracts and for isolated alternariol monomethyl ether.  
Staphylococcus aureus was chosen as a test case for this study because it is a common 
Gram-positive bacterial pathogen (Kaatz and Seo, 1995).  As demonstrated in Table 2, all 
of the botanical extracts demonstrated weak antimicrobial activity, with minimum 
inhibitory concentrations (MICs) of ≥ 300 µg/mL, and IC50 values of ≥ 3 µg/mL.  
Purified alternariol monomethyl ether was slightly more active as an antimicrobial than 
the botanical extracts, with an MIC of 75 µg/mL.  
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Table 2. MIC of Extracts  
Sample MIC 
Areial extract 200 µg/mL  
Seed extract > 200 µg/mL 
berberine 75 µg/mL 
alternariol monomethyl ether 75 µg/mL 
a. MIC is defined as the concentration that caused OD600 to be reduced by ≥ 95%. 
b. Concentration is expressed as µg/mL of plant extract per mL of assay well volume. 
The results for quantitative analysis of alternariol monomethyl ether in the 
botanical extracts provide some context for the findings in Table 2.  This compound was 
found only in a purified fraction of the H. canadensis seed extract, and based on the 
concentration in this extract, the back-calculated concentration of alternariol monomethyl 
ether in the original extract was found to be 991 ppm (expressed as mg of alternariol 
monomethyl ether per Kg of plant material).  At the highest concentration of the seed 
extract tested in the bioassay (200 µg/mL, expressed as mg extract per L assay volume), 
this equates to an assay concentration of only 0.1982 µg/mL alternariol monomethyl 
ether, considerably below the observed MIC of 75 µg/mL for this compound.  Thus, it is 
little surprise that the seed extract did not display marked antimicrobial activity (Table 3).  
However, it is worth noting that many of the fungal endophytes isolated as part of this 
study possessed antimicrobial activity (Table 3), presumably due to the presence of other 
antimicrobial metabolites.  It is entirely possible that the combined effect of multiple low-
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level antimicrobial fungal metabolites could contribute to the overall activity of a 
botanical extract.  Further studies would be necessary to evaluate this possibility.  
The detection of alternariol monomethyl ether in H. canadensis seeds suggests 
that the presence of the fungus may provide some benefit to the plant.   Quantitative 
analysis of the seed extract indicated that alternariol monomethyl ether was present at a 
concentration of approximately 0.072 µg/mL in the extract of the seed material (36% of 
0.2 µg/mL extract), which equates to 991 ppm in the H. canadensis seeds. This 
concentration is above that reported for metabolites known to be ecologically important, 
such as the ergot and loline alkaloids produced by fungal endophytes of native grasses.  
Ergot and loline alkaloid alkaloids help protect grasses from insect herbivores (Bush et 
al., 1997).  In a similar fashion, perhaps the presence of antimicrobial fungal metabolites 
in H. canadensis seeds helps protect from plant bacterial pathogens.  Exploration of this 
hypothesis would be another interesting avenue of further study.  
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CHAPTER III 
METHODS 
Acquisition of Plant Material 
 
 Plant material was harvested from a cultivated plot in Hendersonville, NC 
(N35°24.2770, W 082°20.9930) on 07/11/2011 and a voucher was deposited in the 
University of North Carolina Herbarium (accession number NCU 583414). Additional 
collections were made on 6/28/2012 and 6/11/2015 from the same plot for further 
analysis. For extraction, directly from the plant, the material was allowed to air dry until 
crisp.  Leaves, roots, stems and seeds were separated and ground to a fine powder using a 
Thomas Wiley Mini-Mill. 
Fungal Cultivation and Strain Identification 
 
 Fresh plant samples were surface sterilized as described previously (Raja et al., 
2015). A total of 320 segments were plated, which included 100 stem segments; 100 
leaves; 70 root segments; and 50 seeds. All fungal endophyte cultures that emerged from 
goldenseal plant parts are maintained on Potato Dextrose Agar; Difco (PDA) agar slants 
at 9˚C at the University of North Carolina at Greensboro, Department of Chemistry and 
Biochemistry Fungal Culture Collection. A total of 23 fungi were cultured from tissues of 
H. canadensis (collected on July 11 2011) and were grown on a rice solid-state 
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fermentation medium, as previously described (Raja et al., 2015).  All rice cultures were 
allowed to grow for 14-21 days prior to chemical extraction.  
 For molecular identification of fungal endophytes isolated from goldenseal, the 
internal transcribed spacer region of the ribosomal RNA gene (ITS) was sequenced using 
protocols outlined previously (Raja et al. 2015) and OTU designations as surrogates for 
species identifications were made with BLAST search tool utilizing only authenticated, 
published sequences in NCBI GenBank using 98% identity (Raja et al., 2015; Schoch et 
al., 2014). In addition, phylogenetic analysis of the ITS region using Maximum 
Likelihood was employed to confirm the ITS phylogeny of isolated strains (Data not 
shown). The ITS sequences from all strains were deposited in GenBank and are listed in 
Table 1. 
Extraction and Preparation 
 
 Fungal material and botanical extracts were extracted in 1:1 methanol:chloroform 
and subjected to liquid-liquid partitioning using previously described methods (El‐
Elimat et al., 2015; Kaur et al., 2016; Kellogg et al., 2016; Raja et al., 2015), resulting in 
a chloroform, aqueous, and hexane partitions. The chloroform partitions were of primary 
interest and used for further investigations.   
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Identification of Fungal Metabolites 
 
 Fungal extracts were analyzed using ultra performance liquid chromatography 
(Acquity UPLC, Waters) coupled to high resolving power tandem mass spectrometry 
(LTQ Orbitrap XL, Thermo) (LC-MS-MS) with previously published methods (El-Elimat 
et al., 2013a).  The retention time, accurate mass, and fragmentation spectrum for each 
ion detected were compared to a library of LC-MS data for 262 fungal metabolites to 
identify known compounds (El-Elimat et al., 2013a). Compounds that were not 
represented in the existing fungal library were isolated and characterized via several 
rounds of flash chromatography on a Combiflash Rf system (Teledyne-ISCO, Lincoln, 
NE, USA) and high performance liquid chromatography on the Varian HPLC system 
(Agilent Technologies, Santa Clara, CA, USA), and structures for pure compounds were 
solved based on NMR data (Joel ECS 400Mhz, Joel ECA 500Hhz, Varian 700 MHz) and 
accurate mass measurements, as described previously (Raja et al., 2015).   For each 
isolated compound, NMR and accurate mass data matched literature reports (Table 4).   
 The same method used to collect LC-MS-MS data of fungal extracts was also 
applied to botanical extracts from H. canadensis.  To determine if fungal metabolites 
were detectable in the botanical extracts, the resulting LC-MS data were filtered for the 
m/z value of the [M+H]+ ion of each fungal metabolite. A 5 ppm isolation window was 
used. For identification, comparisons were made between retention time, accurate mass, 
and fragmentation pattern of any ion present in both the botanical and fungal extracts.  
Care was taken to ensure that any fungal metabolites identified in the extracts were not a 
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result of accidental contamination from other fungal samples.  Multiple blank injections 
were conducted between the analysis of each sample, and these blank injections were 
scrutinized to rule out carry-over.   
Quantitative Analysis of Alternariol monomethyl ether 
 
 A stock solution of alternariol monomethyl ether isolated from Alternaria sp. 
(Table 4) was prepared in 50:50 methanol dioxane at a concentration of 1 µg/mL.  The 
identity of this compound was verified by NMR, and its purity was determined to be 
>95% based on UPLC (Kellogg et al., 2016).  Calibration solutions were prepared from 
the stock solution via serial dilution over a concentration range of 0.2 mg/mL to 2 ng/mL. 
These solutions were analyzed using the same LC-MS-MS method applied to the 
extracts, as described previously (El-Elimat et al., 2013a) .  A calibration curve was 
calculated as peak area for the selected [M+H]+ ion for alternariol monomethyl ether (m/z 
273.0755) versus concentration, and alternariol monomethyl ether concentration was 
determined in the fungal and botanical extracts based on the best-fit line for this 
calibration curve.  
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Evaluation of Antimicrobial Activity 
 
 Clinical Laboratory Standards Institute (Ferraro, 2000) methods for broth 
microdilution assays were employed to evaluate the antimicrobial activity of all fungal 
and botanical extracts, as well as the isolated alternariol monomethyl ether. Activity was 
evaluated against Staphylococcus aureus strain SA1199 (Kaatz and Seo, 1995).  The 
known antimicrobial compound berberine served as a positive control for these 
experiments(Junio et al., 2011).  All samples were tested in triplicate with a final DMSO 
content of 2% in each well. Growth was measured based on absorbance measurements at 
600 nm (OD600).  Minimum inhibitory concentration (MIC) was defined as concentration 
at which the mean OD600 of the test wells was reduced by ≥95%. 
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CHAPTER IV 
CONCLUSION 
 The investigation into the presence of fungal components in a botanical medicine 
has shown that although the fungal metabolites can be detected in the original plant 
material.  However, the concentration that they are present in is lower than what would 
be expected to directly contribute to the antimicrobial activity of the plant. Nonetheless, 
the concentration of alternariol monomethylether is higher than concentrations proven to 
be ecologically important for other fungal endophyte secondary metabolites, such as that 
of loline alkaloids, present in some grazing grasses. The findings of this study suggest 
that the fungal secondary metabolites found in these samples may offer some selective 
advantage to the botanical. The findings that Alternaria sp. is found in multiple 
collections of H. canadensis over a multi-year time course supports this hypothesis.   
 Additionally, of the 23 fungal cultures investigated, many proved to be 
antimicrobial against S. aureus, even if the compounds responsible could not be isolated. 
Of the 11 compounds isolated and characterized, 5 had published antimicrobial activity, 
and all had at least some published bioactivity. Therefore, investigations into fungal 
endophytes still show great promise for uncovering bioactive compounds.  
Beyond this study, it is probable that other components that were not identified 
previously could also overlap between the fungal endophytes and the botanicals that they 
19 
 
 
inhabit. Further investigations could shed additional insights into the importance of 
fungal secondary metabolites for the host plants they inhabit.   
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APPENDIX A 
SUPPLEMENTARY DATA 
Table 3. Bioactivity of Fungal Extracts against S.aureus at 20 μg/mL and 200 μg/mL 
(expressed as mass of extract per volume of assay well). 
 
G# OTU identification 20μg/mLa 200μg/mL 
G09 Diaporthe eres 62 (± 13) 99 (± 0.6) 
G10 Diaporthe sp. N.I. N.I. 
G11 Sordariomycete sp. (Xylariales) N.I. N.I. 
G12 Colletotrichum fioriniae N.I. N.I. 
G13 Alternaria sp. 98 (± 1.7) 100 (± 3.0) 
G14 Diaporthe eres N.I. 94 (± 4.0) 
G15 Diaporthe eres N.I. 99 (±0.5) 
G16 Diaporthe sp. 57 (± 33) 99 (± 1.2) 
G17 Diaporthe sp. 60 (± 5.3) 98 (±1.1) 
G22 Phoma sp. 56 (± 5.6) 99 (± 0.4) 
G23 Magnaporthales sp. 33 (± 12) 98 (± 0.3) 
G28 Alternaria sp. 100 (± 1.2) 100 (± 2.0) 
G29 Diaporthe sp. 67 (± 5.5) 90 (± 0.9) 
G30 Colletotrichum fioriniae 58 (± 19) 74 (± 25) 
G31 Alternaria sp. 100 (± 1.1) 100 (± 3.4) 
G33 Alternaria sp. 3.8 (± 29) 100 (± 2.3) 
G34 Colletotrichum fioriniae N.I. N.I. 
G35 Colletotrichum fioriniae 38 (± 15) 60.8 (± 40) 
G36 Alternaria sp. 100 (± 0.4) 100 (± 2.7) 
G38 Colletotrichum fioriniae N.I. 100 (± 2.1) 
G39 Colletotrichum fioriniae 16 (± 1.1) 100 (± 1.0) 
G41 Pyrenochaeta sp. 73 (± 4.6) 73 (± 10) 
G42 Sordariomycete sp. (Xylariales) 36 (± 26) 35 (± 19) 
a.  The known antimicrobial alkaloid berberine served as positive control for these experiments and 
demonstrated an MIC of 75-150ppm, consistent with literature(Amin et al., 1969; Čerňáková and 
Košťálová, 2002).  
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Table 4. Compounds from H. canadensis Endophytic Fungi with Reported 
Biological Activity Indicated.    
Compound Name Reported Activity Found Ina Isolationa  Bioactivity 
Alternariol (1) Antimicrobial G15 (Raistrick et al., 1953) (Raistrick et al., 1953) 
Alternariol monomethyl ether 
(2) 
Antimicrobial/ 
Mycotoxin 
G13,G31 (Bensassi et al., 2011) (Lou et al., 2013) 
5'-epiequisetin (3) Phytotoxin G52 (Wheeler et al., 1999) (Wheeler et al., 1999) 
Equisetin (4) Gram + Antimicrobial G12,G52 
((Burmeister et al., 
1974) 
(Burmeister et al., 1974; 
Wheeler et al., 1999) 
10,11-Dehydrocurvularin (5) HSF1 inhibitor G36 (Hyeon et al., 1976) (Santagata et al., 2011) 
Macrosphelide A (6) Antibiotic G41 
(Takamatsu et al., 
1996) 
(Takamatsu et al., 1996) 
Cordypyridone A (7) Erythropoietin Inducer G16 (Cai et al., 1999) (Cai et al., 1999) 
Sch 52901 (8) Cytotoxic G33 (Chu et al., 1995) (Chu et al., 1995) 
Sch 52900 (9) Cytotoxic G35 (Chu et al., 1995) (Chu et al., 1995) 
 Cytotoxic/ Gram + 
Antimicrobial 
G35 (Katagiri et al., 1970) (Katagiri et al., 1970) 
Verticillin A (10) 
Aurofusarin (11) Mycotoxin 
G12,G30, 
G34,G38 
(Dvorska et al., 2002) (Dvorska et al., 2002) 
 
a.  Compounds 1-7 were identified by isolation and structure elucidation, while 
compounds 8-11 were identified by comparison with a library of LC-MS data (El-
Elimat et al., 2013b).  
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Figure 3. Antimicrobial Activity of a Goldenseal Leaf Extract against 
Staphylococcus aureus.   
 
 
 
 
 
 
 
 
 
 
  
29 
 
 
Figure 4. Antimicrobial Activity of Goldenseal Seed Extract against Staphylococcus 
aureus. 
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Figure 5. Antimicrobial Activity of Alternariol Monomethylether against 
Staphylococcus aureus.   
 
 
 
